PRODUCT LITERATURE
Granisetron reduces postoperative nausea and vomiting throughout menstrual cycle
The treatment groups were similar with respect to patient demographics, types of surgery, anaesthetics administered and analgesics used postoperatively. The incidence of PONV was 72% and 32% in patients during menstruation receiving placebo or granisetron (P < 0.05), and was 46% and 2096 in those during non-menstruation, respectively (P < 0.05). No differences in the incidence of other adverse events were observed among the groups
No other version available